Supplementary Table S2 from A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients

Autor:	Elia Neninger, Tania Crombet, Agustin Lage, Zaima Mazorra, Gryssell Rodríguez, Patricia Sierra, Yaisel Pomares, Nadia Aguilera, Jenelin Parra, Liuba Alonso, Maria A. Marrero, Patricia Lorenzo-Luaces, Carmen Viada, Beatriz Garcia, Yoanna I. Flores, Mauricio Catala, Teresa Sabates, Niurka Futiel, Delmairis Reyes, Loisel Vello, Lina Arzuaga, Mireysi Cala, Ana de la Torre, Gala N. Romero, Yanine Otero, Soraida C. Acosta, Ricardo Fleytas, Rosa M. Amador, Tatiana Crespo, Eduardo Santiesteban, Silvia Mendoza, Odeth Martínez, Xitllaly Popa, Pedro C. Rodriguez
Rok vydání:	2023
Popis:	Overview of all adverse events in the safety evaluable population.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cdcd948022a91a74f0627d93a7352c4 https://doi.org/10.1158/1078-0432.22456914.v1 Zobrazit plný text záznamu